Database | Recombinant Antibodies And Mimetics Database

You are searching for:

Category A

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category B

Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation

Category C

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category D

Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category E

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category F

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with animal-derived biomaterials used in production or final formulation

Category G

Original source/host: Unknown
Discovery method: Unknown
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Uncategorised Antibodies

Uncategorised Antibodies have Antibody/Binder Origins set in such a way as to prevent them from being assigned to a valid Antibody Category.

Click here to view all Antibody Category descriptions and to search directly by Antibody Category

Category A
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category B
- Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
- Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
- Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
Search
Category C
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category D
- Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category E
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category F
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
Search
Category G
- Original source/host: Unknown
- Discovery method: Unknown
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search

291-300 of 5093 results

Catalogue Number:

A25566

Category:

ABflo? 488 Rabbit anti-Human LILRA2/CD85h mAb

Target:	LILRA2
Target Alias Names:	ILT1, LIR7, CD85H, LIR-7
Species Reactivity:	Human
Applications:	Flow Cytometry, Immunofluorescence
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Conjugate:	ABflo? 488. Ex:491nm. Em:516nm.
Formulation:	PBS containing 0.2% BSA, preserved with proclin300 or sodium azide (as specified on the Certificate of Analysis), pH 7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

A23358

Category:

ABflo? 488 Rabbit anti-Human LILRB4/CD85k/ILT3 mAb

Target:	LILRB4
Target Alias Names:	B4, ILT3, LIR5, CD85K, ILT-3, LIR-5
Species Reactivity:	Human
Application:	Flow Cytometry
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Conjugate:	ABflo? 488. Ex:491nm. Em:516nm.
Formulation:	PBS containing 0.2% BSA, preserved with proclin300 or sodium azide (as specified on the Certificate of Analysis), pH 7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

A26562

Category:

ABflo? 488 Rabbit anti-Human MRC2 mAb

Target:	MRC2
Target Alias Names:	CD280, UPARAP, CLEC13E, ENDO180
Species Reactivity:	Human
Application:	Flow Cytometry
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Conjugate:	ABflo? 488. Ex:491nm. Em:516nm.
Formulation:	PBS with 0.09% Sodium azide, 0.2% BSA, pH7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

A25192

Category:

ABflo? 488 Rabbit anti-Human Nectin-4 mAb

Target:	NECTIN4
Target Alias Names:	LNIR, PRR4, EDSS1, PVRL4, nectin-4
Species Reactivity:	Human
Application:	Flow Cytometry
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Conjugate:	ABflo? 488. Ex:491nm. Em:516nm.
Formulation:	PBS containing 0.2% BSA, preserved with proclin300 or sodium azide (as specified on the Certificate of Analysis), pH 7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

A26650

Category:

ABflo? 488 Rabbit anti-Human NT5E/CD73 mAb

Target:	NT5E
Target Alias Names:	NT, eN, NT5, NTE, eNT, CD73, E5NT, CALJA
Species Reactivity:	Human
Application:	Flow Cytometry
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Conjugate:	ABflo? 488. Ex:491nm. Em:516nm.
Formulation:	PBS containing 0.2% BSA, preserved with proclin300 or sodium azide (as specified on the Certificate of Analysis), pH 7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

A24370

Category:

ABflo? 488 Rabbit anti-Human OPN1LW/OPN1MW mAb

Target:	OPN1LW/OPN1MW
Target Alias Names:	CBP, RCP, ROP, CBBM, COD5, CBD, GCP, GOP, CBBM, COD5, OPN1MW1
Species Reactivity:	Human
Application:	Flow Cytometry
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Conjugate:	ABflo? 488. Ex:491nm. Em:516nm.
Formulation:	PBS containing 0.2% BSA, preserved with proclin300 or sodium azide (as specified on the Certificate of Analysis), pH 7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

AP1487

Category:

ABflo? 488 Rabbit anti-Human Phospho-PI3KP85α-Y467+P85β-Y464+P55γ-Y199 mAb

Target:	PIK3R1/PIK3R2/PIK3R3
Target Alias Name:	PIK3R1/PIK3R2/PIK3R3
Species Reactivity:	Human
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Conjugate:	ABflo? 488. Ex:491nm. Em:516nm.
Formulation:	PBS containing 0.2% BSA, preserved with proclin300 or sodium azide (as specified on the Certificate of Analysis), pH 7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

A24408

Category:

ABflo? 488 Rabbit anti-Human Podoplanin mAb

Target:	PDPN
Target Alias Names:	PDPN, AGGRUS, GP36, GP40, Gp38, HT1A-1, OTS8, PA2.26, T1A, T1A-2, T1A2, TI1A, podoplanin
Species Reactivity:	Human
Application:	Flow Cytometry
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Conjugate:	ABflo? 488. Ex:491nm. Em:516nm.
Formulation:	PBS containing 0.2% BSA, preserved with proclin300 or sodium azide (as specified on the Certificate of Analysis), pH 7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

A24633

Category:

ABflo? 488 Rabbit anti-Human PU.1/SPI1 mAb

Target:	SPI1
Target Alias Names:	SPI1, OF, PU.1, SFPI1, SPI-1, SPI-A, Spi-1 proto-oncogene
Species Reactivity:	Human
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Conjugate:	ABflo? 488. Ex:491nm. Em:516nm.
Formulation:	PBS containing 0.2% BSA, preserved with proclin300 or sodium azide (as specified on the Certificate of Analysis), pH 7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

A26760

Category:

ABflo? 488 Rabbit anti-Human RANKL/CD254 mAb

Target:	TNFSF11
Target Alias Names:	ODF, OPGL, sOdf, CD254, OPTB2, RANKL, TNLG6B, TRANCE, hRANKL2
Species Reactivity:	Human
Type:	Secondary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Conjugate:	ABflo? 488. Ex:491nm. Em:516nm.
Formulation:	PBS with 0.09% Sodium azide, 0.2% BSA, pH7.3.
Animal-Derived Biomaterials Used:	BSA
Sequence Available	No
Original Discovery Method	Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Viewing 291-300 of 5093 results

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.